Lupin500257Pharmaceuticals
Analyst gave support and target levels for Lupin
By ScoutQuest · · 1 min read
- Buy price
- 2,064
- Support level
- 1,920
- Trigger level
- 1,800
- Target level
- 2,060
Heard on business television between 10:51:45 - 10:54:45 IST.
- Viewer Shahan held shares bought at 2,064
- Vaishali said support range around 1,920
- Said if it crosses 1,800 should look at target of 2,060
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Lupin
Lupin receives U.S. FDA approval for Amifampridine Tablets, 10 mg, and is eligible for 180-day shared generic exclusivity
2 Nov 2026
Lupin saw buy flows on the PMS desk with dealers expecting strong Q2 earnings
29 Oct 2026
Lupin stock continued building on gains after positive management commentary on its Q2 earnings call
28 Oct 2026
Source: Live TV News Channel · 28 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.